利巴韦林治疗急性上呼吸道感染60例临床分析

Clinical Analysis of 60 Patients with Acute Upper Respiratory Tract Infection Treated by Ribavirin

目的:探讨利巴韦林治疗急性上呼吸道感染的临床效果。方法:将我院2011年1月至2012年12月收治的急性上呼吸道感染患者120例随机分为观察组和对照组各60例,分别应用利巴韦林和阿奇霉素治疗,比较两组的疗效和不良反应。结果:观察组疗效明显优于对照组,且不良反应发生率也明显低于对照组,P均<0.05。结论:与阿奇霉素相比,利巴韦林治疗急性上呼吸道感染可提高临床疗效,且副作用小。

Objective： To explore the clinical effect of patients with acute upper respiratory tract infection treated by Ribavirin. Methods： 120 patients with acute upper respiratory tract infection were randomly divided into observation group and control group, each group was 60 cases. The control group was given Azithromycin and the observation group was given Ribavirin. The clinical effect and adverse reactions were compared between the two groups. Results： The curative effect in the observation group was significantly better than that in the control group, and the incidence of adverse reactions in the observation group was significantly lower than those in the control group, both P 〈 0.05. Conclusion： Compared with Azithromycin, using Ribavirin in treatment of acute upper respiratory tract infection may improve the clinical curative effect and little adverse reactions.